Tubulin Inhibiting Agent [EPC]

Tubulin Inhibiting Agent [EPC] was reported 291 times

Drugs of the Tubulin Inhibiting Agent [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CARD9 DEFICIENCY 4 1.0000
1 ADENOSINE DEAMINASE DEFICIENCY 1 1.0000
2 TRICHOPHYTIC GRANULOMA 2 0.0426
3 GASTROENTERITIS SHIGELLA 1 0.0270
4 TINEA CAPITIS 2 0.0174
5 DYSMETROPSIA 1 0.0154
6 DERMATOPHYTOSIS 3 0.0106
7 MEDICATION TAMPERING 1 0.0100
8 TRICHOPHYTOSIS 2 0.0094
9 SHIGELLA INFECTION 1 0.0088
10 PITYRIASIS RUBRA PILARIS 2 0.0084
11 BREAST INFECTION 1 0.0083
12 DUODENITIS HAEMORRHAGIC 1 0.0072
13 ANASTOMOTIC ULCER HAEMORRHAGE 1 0.0070
14 BLOOD PRESSURE ORTHOSTATIC ABNORMAL 1 0.0065
15 CHONDRITIS 1 0.0057
16 ABSCESS FUNGAL 1 0.0057
17 COMPLEMENT FACTOR C4 DECREASED 1 0.0052
18 VIRAL RASH 2 0.0049
19 GLOMERULONEPHRITIS ACUTE 1 0.0049
20 LINEAR IGA DISEASE 8 0.0048
21 LICE INFESTATION 1 0.0048
22 PELVIC HAEMATOMA 2 0.0045
23 GASTROOESOPHAGEAL SPHINCTER INSUFFICIENCY 1 0.0045
24 JARISCH-HERXHEIMER REACTION 3 0.0042
25 COMPLEMENT FACTOR C3 DECREASED 1 0.0041
26 ICHTHYOSIS 1 0.0040
27 GASTRIC BANDING 1 0.0038
28 POST CHOLECYSTECTOMY SYNDROME 1 0.0035
29 GENITAL EROSION 1 0.0034
30 METASTASES TO HEART 1 0.0033
31 CEREBRAL TOXOPLASMOSIS 3 0.0032
32 GLOMERULOSCLEROSIS 2 0.0032
33 COLD-STIMULUS HEADACHE 1 0.0031
34 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5 0.0031
35 CATHETER SITE BRUISE 1 0.0030
36 PERIVASCULAR DERMATITIS 1 0.0030
37 TINEA VERSICOLOUR 1 0.0028
38 GLOMERULONEPHRITIS PROLIFERATIVE 1 0.0028
39 VENOUS INSUFFICIENCY 2 0.0028
40 SYPHILIS 2 0.0028
41 GRANDIOSITY 1 0.0027
42 TINEA INFECTION 3 0.0027
43 OBSESSIVE-COMPULSIVE SYMPTOM 1 0.0027
44 MIXED CONNECTIVE TISSUE DISEASE 1 0.0024
45 POST INFLAMMATORY PIGMENTATION CHANGE 1 0.0022
46 IMMUNOGLOBULINS INCREASED 1 0.0021
47 CUTANEOUS LUPUS ERYTHEMATOSUS 4 0.0021
48 PHARYNGEAL ABSCESS 1 0.0020
49 OESOPHAGEAL ULCER HAEMORRHAGE 1 0.0020
50 URETHRITIS 1 0.0018
51 GASTROENTERITIS ESCHERICHIA COLI 1 0.0018
52 CEREBELLAR INFARCTION 3 0.0018
53 XEROSIS 2 0.0016
54 PRESSURE OF SPEECH 1 0.0015
55 CHONDROCALCINOSIS 1 0.0015
56 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 1 0.0015
57 KERATOACANTHOMA 1 0.0015
58 PEPTIC ULCER HAEMORRHAGE 1 0.0014
59 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
60 VIOLENCE-RELATED SYMPTOM 2 0.0013
61 GIANT CELL ARTERITIS 1 0.0012
62 PERITONSILLAR ABSCESS 1 0.0012
63 UPPER AIRWAY OBSTRUCTION 1 0.0011
64 PATHOGEN RESISTANCE 10 0.0011
65 MUSCLE SWELLING 1 0.0011
66 CATHETER SITE SWELLING 1 0.0011
67 EPIDERMAL NECROSIS 1 0.0010
68 MULTIPLE-DRUG RESISTANCE 3 0.0010
69 TOXOPLASMOSIS 1 0.0009
70 CARBON DIOXIDE DECREASED 1 0.0009
71 DILATATION ATRIAL 1 0.0009
72 MORBID THOUGHTS 1 0.0009
73 GLOMERULONEPHRITIS MEMBRANOUS 1 0.0009
74 ORAL MUCOSA EROSION 1 0.0008
75 NEPHRITIS INTERSTITIAL 1 0.0008
76 ADJUSTMENT DISORDER 1 0.0008
77 ACROCHORDON 1 0.0008
78 ERYTHEMA MULTIFORME 7 0.0007
79 HALLUCINATIONS, MIXED 3 0.0007
80 GASTRITIS HAEMORRHAGIC 1 0.0007
81 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0006
82 ILLUSION 1 0.0006
83 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
84 ROTATOR CUFF REPAIR 1 0.0006
85 BREAST CYST 1 0.0006
86 HYPERKERATOSIS 3 0.0005
87 INTENTIONAL MISUSE 1 0.0005
88 SMALL INTESTINAL HAEMORRHAGE 1 0.0005
89 LYMPHOCYTOSIS 1 0.0005
90 APPLICATION SITE SCAB 1 0.0005
91 ONYCHOMYCOSIS 2 0.0005
92 APPLICATION SITE URTICARIA 1 0.0004
93 DIVERTICULUM INTESTINAL HAEMORRHAGIC 1 0.0004
94 METASTATIC MALIGNANT MELANOMA 1 0.0004
95 SARCOIDOSIS 2 0.0004
96 PULSE ABNORMAL 1 0.0004
97 RASH PUSTULAR 3 0.0004
98 STEVENS-JOHNSON SYNDROME 9 0.0004
99 ACUTE PSYCHOSIS 1 0.0004
100 DERMATITIS EXFOLIATIVE 2 0.0004
101 PEMPHIGOID 3 0.0004
102 BLOOD PHOSPHORUS INCREASED 1 0.0004
103 SKIN HYPERTROPHY 1 0.0004
104 DRUG RESISTANCE 9 0.0004
105 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 9 0.0003
106 DUODENAL ULCER HAEMORRHAGE 1 0.0003
107 VITAMIN B12 DECREASED 1 0.0003
108 SQUAMOUS CELL CARCINOMA OF SKIN 2 0.0003
109 REBOUND ACID HYPERSECRETION 1 0.0003
110 TOXIC EPIDERMAL NECROLYSIS 5 0.0003
111 SELF INJURIOUS BEHAVIOUR 1 0.0003
112 EOSINOPHILIC PNEUMONIA 1 0.0003
113 SKIN EROSION 1 0.0003
114 INCOHERENT 2 0.0003
115 INCORRECT DISPOSAL OF PRODUCT 1 0.0003
116 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
117 POSTURE ABNORMAL 1 0.0003
118 LISTLESS 1 0.0003
119 MENINGITIS 2 0.0003
120 ECCHYMOSIS 2 0.0003
121 ENCEPHALITIS 2 0.0003
122 GRANULOMA 1 0.0003
123 APPARENT DEATH 1 0.0003
124 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
125 HYPOALBUMINAEMIA 2 0.0003
126 SKIN ODOUR ABNORMAL 1 0.0003
127 CANDIDIASIS 1 0.0002
128 ENURESIS 1 0.0002
129 SELF-MEDICATION 1 0.0002
130 ACCIDENTAL EXPOSURE 1 0.0002
131 SLEEP TERROR 1 0.0002
132 AORTIC VALVE INCOMPETENCE 1 0.0002
133 DELIRIUM 8 0.0002
134 ORAL CANDIDIASIS 3 0.0002
135 RASH MACULO-PAPULAR 5 0.0002
136 LOCALISED OEDEMA 1 0.0002
137 NEPHROGENIC ANAEMIA 1 0.0002
138 HEPATOMEGALY 2 0.0002
139 SPRUE-LIKE ENTEROPATHY 1 0.0002
140 APPLICATION SITE SWELLING 1 0.0002
141 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
142 CHEILITIS 1 0.0002
143 NONSPECIFIC REACTION 1 0.0002
144 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
145 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
146 GASTRIC ULCER HAEMORRHAGE 1 0.0002
147 GRANULOCYTOPENIA 1 0.0002
148 VENTRICULAR SEPTAL DEFECT 1 0.0002
149 METABOLIC DISORDER 1 0.0002
150 LYMPHADENOPATHY 6 0.0002
151 HYPERLIPIDAEMIA 2 0.0002
152 HEPATITIS B 1 0.0002
153 GANGRENE 1 0.0002
154 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
155 INFUSION SITE EXTRAVASATION 1 0.0002
156 PROTEINURIA 3 0.0002
157 SCREAMING 1 0.0002
158 WRONG PRODUCT ADMINISTERED 1 0.0001
159 CORONARY ARTERY OCCLUSION 2 0.0001
160 LYMPHOEDEMA 1 0.0001
161 HAIR GROWTH ABNORMAL 1 0.0001
162 DIVERTICULUM 1 0.0001
163 DERMATITIS BULLOUS 1 0.0001
164 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
165 BLOOD ALBUMIN DECREASED 1 0.0001
166 SPINAL COMPRESSION FRACTURE 1 0.0001
167 SKIN PLAQUE 1 0.0001
168 RASH GENERALISED 3 0.0001
169 RASH MACULAR 4 0.0001
170 URINE OUTPUT DECREASED 1 0.0001
171 ANHEDONIA 3 0.0001
172 EOSINOPHILIA 2 0.0001
173 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
174 PURPURA 1 0.0001
175 WRONG DRUG ADMINISTERED 1 0.0001
176 HAEMOLYTIC ANAEMIA 1 0.0001
177 MYOSITIS 1 0.0001
178 GASTROENTERITIS VIRAL 2 0.0001
179 LUPUS-LIKE SYNDROME 1 0.0001
180 END STAGE RENAL DISEASE 2 0.0001
181 INCREASED TENDENCY TO BRUISE 1 0.0001
182 UROSEPSIS 1 0.0001
183 HEPATIC FUNCTION ABNORMAL 4 0.0001
184 NEPHROPATHY 1 0.0001
185 APPENDICITIS 1 0.0001
186 SQUAMOUS CELL CARCINOMA 1 0.0001
187 HYPERCHOLESTEROLAEMIA 1 0.0001
188 PARKINSONISM 1 0.0001
189 INFLAMMATORY BOWEL DISEASE 1 0.0001
190 ACUTE MYOCARDIAL INFARCTION 3 0.0001
191 TOXIC SKIN ERUPTION 1 0.0001
192 SUBARACHNOID HAEMORRHAGE 1 0.0001
193 DERMATITIS 2 0.0001
194 INJECTION SITE DISCOMFORT 1 0.0001
195 PHARYNGITIS STREPTOCOCCAL 1 0.0001
196 BIPOLAR DISORDER 1 0.0001
197 OESOPHAGITIS 1 0.0001
198 ASPIRATION 1 0.0001
199 BLOOD GLUCOSE FLUCTUATION 1 0.0001
200 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
201 APPLICATION SITE PAIN 2 0.0001
202 MALNUTRITION 1 0.0001
203 FISTULA 1 0.0001
204 CHOLECYSTECTOMY 1 0.0001
205 GASTRIC HAEMORRHAGE 1 0.0001
206 METASTASES TO LUNG 1 0.0001
207 VASCULITIS 1 0.0001
208 SPLENOMEGALY 1 0.0001
209 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
210 TREATMENT FAILURE 7 0.0001
211 DISEASE RECURRENCE 4 0.0001
212 CHOLECYSTITIS 1 0.0001
213 ADRENAL INSUFFICIENCY 1 0.0001
214 HAIR COLOUR CHANGES 1 0.0001
215 HIATUS HERNIA 1 0.0001
216 PLATELET COUNT INCREASED 1 0.0001
217 ECZEMA 4 0.0001
218 SOPOR 1 0.0001
219 PRODUCT TASTE ABNORMAL 1 0.0001
220 IMPAIRED GASTRIC EMPTYING 1 0.0001
221 MENTAL STATUS CHANGES 2 0.0001
222 ORAL DISCOMFORT 1 0.0001
223 SKIN EXFOLIATION 6 0.0001
224 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
225 PARALYSIS 1 0.0001
226 URINARY INCONTINENCE 2 0.0001
227 SKIN HAEMORRHAGE 1 0.0001
228 PULMONARY MASS 1 0.0001
229 BONE LOSS 1 0.0001
230 BLOOD POTASSIUM DECREASED 2 0.0001
231 OSTEOPENIA 1 0.0001
232 DRUG DISPENSING ERROR 1 0.0001
233 THERAPY PARTIAL RESPONDER 1 0.0001
234 SICKLE CELL ANAEMIA WITH CRISIS 1 0.0001
235 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
236 HALLUCINATION, AUDITORY 1 0.0001
237 RASH ERYTHEMATOUS 3 0.0001
238 ABSCESS 1 0.0001
239 PHOTOSENSITIVITY REACTION 1 0.0001
240 FACE OEDEMA 1 0.0001
241 COLD SWEAT 1 0.0001
242 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
243 DRUG ERUPTION 1 0.0001
244 THIRST 1 0.0001
245 GOUT 1 0.0001
246 LEUKOCYTOSIS 1 0.0001
247 C-REACTIVE PROTEIN INCREASED 2 0.0001
248 CONJUNCTIVITIS 1 0.0001
249 BLOOD SODIUM DECREASED 1 0.0001
250 CHRONIC KIDNEY DISEASE 4 0.0001
251 SLEEP APNOEA SYNDROME 1 0.0001
252 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
253 ABNORMAL BEHAVIOUR 2 0.0001
254 DRUG INTERACTION 8 0.0001
255 PRODUCT PHYSICAL ISSUE 1 0.0000
256 INTENTIONAL SELF-INJURY 1 0.0000
257 THERAPEUTIC RESPONSE DECREASED 3 0.0000
258 FEEDING DISORDER 1 0.0000
259 OEDEMA PERIPHERAL 6 0.0000
260 BODY TEMPERATURE INCREASED 1 0.0000
261 PULMONARY HYPERTENSION 1 0.0000
262 KNEE ARTHROPLASTY 1 0.0000
263 RETCHING 1 0.0000
264 IRRITABLE BOWEL SYNDROME 1 0.0000
265 SEPTIC SHOCK 2 0.0000
266 BLOOD CREATININE INCREASED 3 0.0000
267 PRODUCT DISPENSING ERROR 1 0.0000
268 PRODUCT PRESCRIBING ISSUE 1 0.0000
269 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
270 ACUTE KIDNEY INJURY 7 0.0000
271 RENAL FAILURE 6 0.0000
272 TRANSAMINASES INCREASED 1 0.0000
273 PRODUCT AVAILABILITY ISSUE 1 0.0000
274 SKIN DISCOLOURATION 2 0.0000
275 MUSCLE TWITCHING 1 0.0000
276 PERICARDIAL EFFUSION 1 0.0000
277 PRODUCT PRESCRIBING ERROR 1 0.0000
278 FIBROMYALGIA 1 0.0000
279 PRESYNCOPE 1 0.0000
280 CEREBRAL INFARCTION 1 0.0000
281 ABASIA 1 0.0000
282 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
283 AGEUSIA 1 0.0000
284 LEUKOPENIA 2 0.0000
285 AGGRESSION 2 0.0000
286 CELLULITIS 2 0.0000
287 CARDIOVASCULAR DISORDER 1 0.0000
288 HEPATITIS 1 0.0000
289 UNRESPONSIVE TO STIMULI 1 0.0000
290 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
291 DEAFNESS 1 0.0000
292 SPEECH DISORDER 2 0.0000
293 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
294 JAUNDICE 1 0.0000
295 PAIN OF SKIN 1 0.0000
296 DISTURBANCE IN ATTENTION 2 0.0000
297 BLOOD BILIRUBIN INCREASED 1 0.0000
298 LIMB INJURY 1 0.0000
299 PALLOR 1 0.0000
300 TREATMENT NONCOMPLIANCE 2 0.0000
301 SKIN LESION 1 0.0000
302 MEDICATION ERROR 2 0.0000
303 BLISTER 2 0.0000
304 ASTHMA 4 0.0000
305 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
306 LETHARGY 2 0.0000
307 BALANCE DISORDER 3 0.0000
308 LIVER FUNCTION TEST ABNORMAL 1 0.0000
309 ASCITES 1 0.0000
310 PSYCHOTIC DISORDER 1 0.0000
311 RENAL INJURY 1 0.0000
312 IRRITABILITY 2 0.0000
313 HEPATIC FAILURE 1 0.0000
314 EMOTIONAL DISTRESS 4 0.0000
315 CORONARY ARTERY DISEASE 1 0.0000
316 SUICIDE ATTEMPT 2 0.0000
317 VERTIGO 2 0.0000
318 EPILEPSY 1 0.0000
319 BONE DENSITY DECREASED 1 0.0000
320 DRUG-INDUCED LIVER INJURY 1 0.0000
321 PYREXIA 11 0.0000
322 HEAD INJURY 1 0.0000
323 PRODUCT DOSE OMISSION 2 0.0000
324 OSTEONECROSIS 1 0.0000
325 STAPHYLOCOCCAL INFECTION 1 0.0000
326 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
327 VIRAL INFECTION 1 0.0000
328 LIP SWELLING 1 0.0000
329 FUNGAL INFECTION 1 0.0000
330 GAIT INABILITY 1 0.0000
331 URTICARIA 5 0.0000
332 RASH 13 0.0000
333 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
334 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
335 DRUG INEFFECTIVE 39 0.0000
336 ANGER 1 0.0000
337 HAEMOGLOBIN DECREASED 3 0.0000
338 HAEMATURIA 1 0.0000
339 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
340 BURNING SENSATION 2 0.0000
341 HEART RATE DECREASED 1 0.0000
342 INJURY 2 0.0000
343 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
344 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
345 CEREBRAL HAEMORRHAGE 1 0.0000
346 INFECTION 4 0.0000
347 RESTLESSNESS 1 0.0000
348 AGITATION 2 0.0000
349 DYSGEUSIA 2 0.0000
350 THROMBOCYTOPENIA 3 0.0000
351 BLOOD GLUCOSE INCREASED 5 0.0000
352 INTESTINAL OBSTRUCTION 1 0.0000
353 GAIT DISTURBANCE 5 0.0000
354 PLASMA CELL MYELOMA 1 0.0000
355 HEADACHE 16 0.0000
356 DISORIENTATION 1 0.0000
357 THROMBOSIS 2 0.0000
358 ANXIETY 7 0.0000
359 OSTEOPOROSIS 1 0.0000
360 RHABDOMYOLYSIS 1 0.0000
361 POLLAKIURIA 1 0.0000
362 ROAD TRAFFIC ACCIDENT 1 0.0000
363 OSTEOARTHRITIS 1 0.0000
364 RENAL FAILURE ACUTE 1 0.0000
365 RECTAL HAEMORRHAGE 1 0.0000
366 HYPOACUSIS 1 0.0000
367 DEVICE DISLOCATION 1 0.0000
368 PRODUCT STORAGE ERROR 2 0.0000
369 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
370 LIVER DISORDER 1 0.0000
371 DEHYDRATION 3 0.0000
372 COLITIS ULCERATIVE 1 0.0000
373 PULMONARY OEDEMA 1 0.0000
374 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
375 THERAPY NON-RESPONDER 1 0.0000
376 TINNITUS 1 0.0000
377 HYPOKALAEMIA 1 0.0000
378 COGNITIVE DISORDER 1 0.0000
379 NEUROPATHY PERIPHERAL 2 0.0000
380 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
381 CONTUSION 2 0.0000
382 ALOPECIA 4 0.0000
383 PRODUCT USE IN UNAPPROVED INDICATION 5 0.0000
384 SYNCOPE 2 0.0000
385 CHEST DISCOMFORT 2 0.0000
386 PARAESTHESIA 3 0.0000
387 DEPRESSED MOOD 1 0.0000
388 PLATELET COUNT DECREASED 2 0.0000
389 DRUG EFFECT DECREASED 1 0.0000
390 CONFUSIONAL STATE 3 0.0000
391 RASH PRURITIC 1 0.0000
392 SEPSIS 2 0.0000
393 PANCYTOPENIA 1 0.0000
394 WEIGHT INCREASED 4 0.0000
395 OXYGEN SATURATION DECREASED 1 0.0000
396 HYPONATRAEMIA 1 0.0000
397 FLATULENCE 1 0.0000
398 MUSCULAR WEAKNESS 2 0.0000
399 DEPRESSION 4 0.0000
400 CONVULSION 1 0.0000
401 SEIZURE 2 0.0000
402 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
403 MYOCARDIAL INFARCTION 3 0.0000
404 ABDOMINAL PAIN 4 0.0000
405 COVID-19 3 0.0000
406 WHEEZING 1 0.0000
407 CATARACT 1 0.0000
408 ILL-DEFINED DISORDER 1 0.0000
409 DISCOMFORT 1 0.0000
410 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
411 PAIN 10 0.0000
412 CHEST PAIN 3 0.0000
413 DIZZINESS 8 0.0000
414 OFF LABEL USE 14 0.0000
415 ANAEMIA 3 0.0000
416 INTENTIONAL OVERDOSE 1 0.0000
417 HYPERHIDROSIS 2 0.0000
418 DIARRHOEA 10 0.0000
419 AMNESIA 1 0.0000
420 PSORIASIS 2 0.0000
421 INFUSION RELATED REACTION 1 0.0000
422 NEOPLASM MALIGNANT 1 0.0000
423 NEUTROPENIA 2 0.0000
424 HEPATIC ENZYME INCREASED 1 0.0000
425 RESPIRATORY FAILURE 1 0.0000
426 UNEVALUABLE EVENT 1 0.0000
427 DECREASED APPETITE 3 0.0000
428 BACK PAIN 3 0.0000
429 ARTHRITIS 1 0.0000
430 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
431 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
432 INFLUENZA LIKE ILLNESS 1 0.0000
433 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
434 ABDOMINAL DISCOMFORT 2 0.0000
435 URINARY TRACT INFECTION 2 0.0000
436 TACHYCARDIA 1 0.0000
437 DEVICE ISSUE 1 0.0000
438 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
439 SUICIDAL IDEATION 1 0.0000
440 MUSCLE SPASMS 2 0.0000
441 ADVERSE EVENT 1 0.0000
442 NASOPHARYNGITIS 2 0.0000
443 OROPHARYNGEAL PAIN 1 0.0000
444 HYPERSENSITIVITY 2 0.0000
445 BREAST CANCER 1 0.0000
446 SWELLING 1 0.0000
447 PRODUCT USE ISSUE 2 0.0000
448 VOMITING 5 0.0000
449 PULMONARY EMBOLISM 1 0.0000
450 MIGRAINE 1 0.0000
451 FATIGUE 8 0.0000
452 PAIN IN EXTREMITY 3 0.0000
453 DYSPEPSIA 1 0.0000
454 CONDITION AGGRAVATED 3 0.0000
455 ILLNESS 1 0.0000
456 ABDOMINAL DISTENSION 1 0.0000
457 HAEMORRHAGE 1 0.0000
458 HYPERTENSION 2 0.0000
459 PNEUMONIA 3 0.0000
460 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
461 CONSTIPATION 2 0.0000
462 MALAISE 4 0.0000
463 INFLUENZA 1 0.0000
464 NAUSEA 7 0.0000
465 DYSPNOEA 5 0.0000
466 RHEUMATOID ARTHRITIS 1 0.0000
467 FEELING ABNORMAL 2 0.0000
468 JOINT SWELLING 1 0.0000
469 PRURITUS 3 0.0000
470 DRY SKIN 1 0.0000
471 PRODUCT QUALITY ISSUE 1 0.0000
472 VISION BLURRED 1 0.0000
473 MEMORY IMPAIRMENT 1 0.0000
474 ARTHRALGIA 3 0.0000
475 COUGH 2 0.0000
476 DEATH 6 0.0000
477 PRODUCT DOSE OMISSION ISSUE 2 0.0000
478 INJECTION SITE PAIN 2 0.0000
479 PERIPHERAL SWELLING 1 0.0000
480 DRUG DEPENDENCE 1 0.0000
481 DRUG DOSE OMISSION 1 0.0000
482 TREMOR 1 0.0000
483 FALL 2 0.0000
484 CEREBROVASCULAR ACCIDENT 1 0.0000
485 MYALGIA 1 0.0000
486 NO ADVERSE EVENT 1 0.0000
487 ASTHENIA 2 0.0000
488 SOMNOLENCE 1 0.0000
489 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
490 ERYTHEMA 1 0.0000
491 ABDOMINAL PAIN UPPER 1 0.0000
492 OVERDOSE 1 0.0000
493 INCORRECT DOSE ADMINISTERED 1 0.0000
494 INSOMNIA 1 0.0000
495 WEIGHT DECREASED 1 0.0000